Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes

Journal of Human Hypertension

Volumn 21, Issue 9, 2007, Pages 709-716

  Sarafidis, P A ^a,b   Lasaridis, A N ^a   Nilsson, P M ^c   Pikilidou, M I ^a   Stafilas, P C ^a   Kanaki, A ^a   Kazakos, K ^a   Yovos, J ^a   Bakris, G L ^b  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY WEIGHT; CORRELATION ANALYSIS; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; RELIABILITY; REPRODUCIBILITY; TRIACYLGLYCEROL BLOOD LEVEL; VALIDITY;

EID: 34548336411     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002201     Document Type: Article

References (41)

1. Sarafidis PA, Nilsson PM. The metabolic syndrome: A glance at its history. J Hypertens 2006; 24: 621-626.
2. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
3. Hanley AJ, Williams K, Stern MP, Haffner SM. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: The San Antonio Heart Study. Diabetes Care 2002; 25: 1177-1184.
4. Pyorala M, Miettinen H, Laakso M, Pyorala K. Plasma insulin and all-cause, cardiovascular, and noncardiovascular mortality: The 22-year follow-up results of the Helsinki Policemen Study. Diabetes Care 2000; 23: 1097-1102.
5. Beck-Nielsen H, Groop LC. Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. J Clin Invest 1994; 94: 1714-1721.
6. Turner NC, Clapham JC. Insulin resistance, impaired glucose tolerance and non-insulin-dependent diabetes, pathologic mechanisms and treatment: current status and therapeutic possibilities. Prog Drug Res 1998; 51: 33-94.
7. McFarlane SI, Banerji M, Sowers JR. Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab 2001; 86: 713-718.
8. Sarafidis PA, Lasaridis AN. Actions of PPARγ agonists explaining a possible blood pressure lowering effect. Am J Hypertens 2006; 19: 646-653.
9. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: 214-223.
10. Ferrannini E, Mari A. How to measure insulin sensitivity. J Hypertens 1998; 16: 895-906.
11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
12. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G et al. Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402-2410.
13. Emoto M, Nishizawa Y, Maekawa K, Hiura Y, Kanda H, Kawagishi T et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 1999; 22: 818-822.
14. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57-63.
15. Ikeda Y, Suehiro T, Nakamura T, Kumon Y, Hashimoto K. Clinical significance of the insulin resistance index as assessed by homeostasis model assessment. Endocr J 2001; 48: 81-86.
16. Bastard JP, Rabasa-Lhoret R, Maachi M, Ducluzeau PH, Andreelli F, Vidal H et al. What kind of simple fasting index should be used to estimate insulin sensitivity in humans? Diabetes Metab 2003; 29 285-288.
17. Kirwan JP, Huston-Presley L, Kalhan SC, Catalano PM. Clinically useful estimates of insulin sensitivity during pregnancy: Validation studies in women with normal glucose tolerance and gestational diabetes mellitus. Diabetes Care 2001; 24: 1602-1607.
18. Gungor N, Saad R, Janosky J, Arslanian S. Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. J Pediatr 2004; 144: 47-55.
19. Yokoyama H, Emoto M, Fujiwara S, Motoyama K, Morioka T, Komatsu M et al. Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients. Diabetes Care 2003; 26: 2426-2432.
20. Yokoyama H, Emoto M, Fujiwara S, Motoyama K, Morioka T, Komatsu M et al. Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment are useful indexes of insulin resistance in type 2 diabetic patients with wide range of fasting plasma glucose. J Clin Endocrinol Metab 2004; 89: 1481-1484.
21. McAuley KA, Williams SM, Mann JI, Walker RJ, Lewis-Barned NJ, Temple LA et al. Diagnosing insulin resistance in the general population. Diabetes Care 2001; 24: 460-464.
22. Mather KJ, Hunt AE, Steinberg HO, Paradisi G, Hook G, Katz A et al. Repeatability characteristics of simple indices of insulin resistance: Implications for research applications. J Clin Endocrinol Metab 2001; 86: 5457-5464.
23. Houtkooper LB, Lohman TG, Going SB, Howell WH. Why bioelectrical impedance analysis should be used for estimating adiposity. Am J Clin Nutr 1996; 64(Suppl): 436S-448S.
24. NIH Consensus statement. Bioelectrical impedance analysis in body composition measurement. National Institutes of Health Technology Assessment Conference Statement. December 12-14, 1994. Nutrition 1996; 12: 749-762.
25. Voss EM, Cembrowski GS. Performance characteristics of the HemoCue B-glucose analyzer using whole-blood samples. Arch Pathol Lab Med 1993; 117: 711-713.
26. Sarafidis PA, Lasaridis AN, Nilsson PM, Pagkalos EM, Hitoglou-Makedou AD, Pliakos CI et al. Ambulatory, blood pressure reduction after rosiglitazone treatment in patients with type 2 diabetes and hypertension correlates with insulin sensitivity increase. J Hypertens 2004; 22: 1769-1777.
27. World Health Organization. Definition Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation. Part 1: Diagnosis and classification of diabetes mellitus. World Health Organization: Geneva, 1999.
28. Laakso M, Sarlund H, Mykkanen L. Essential hypertension and insulin resistance in non-insulin-dependent diabetes. Eur J Clin Invest 1989; 19: 518-526.
29. Kashiwabara H, Inaba M, Maruno Y, Morita T, Awata T, Negishi K et al. Insulin levels during fasting and the glucose tolerance test and Homa's index predict subsequent development of hypertension. J Hypertens 2000; 18: 83-88.
30. Cheng C, Campbell KL, Kushner H, Falkner BE. Correlation of oral glucose tolerance test-derived estimates of insulin sensitivity with insulin clamp measurements in an African-American cohort. Metabolism 2004; 53: 1107-1112.
31. Straczkowski M, Stepien A, Kowalska I, Kinalska I. Comparison of simple indices of insulin sensitivity using the euglycemic hyperinsulinemic clamp technique. Med Sci Monit 2004; 10: 480-484.
32. Conwell LS, Trost SG, Brown WJ, Batch JA. Indexes of insulin resistance and secretion in obese children and adolescents: A validation study. Diabetes Care 2004; 27: 314-319.
33. Katsuki A, Sumida Y, Urakawa H, Gabazza EC, Murashima S, Morioka K et al. Neither homeostasis model assessment nor quantitative insulin sensitivity check index can predict insulin resistance in elderly patients with poorly controlled type 2 diabetes mellitus. J Clin Endocrinol Metab 2002; 87: 5332-5335.
34. Diamanti-Kandarakis E, Kouli C, Alexandraki K, Spina G. Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004; 89: 1273-1276.
35. Lansang MC, Williams GH, Carroll JS. Correlation between the glucose clamp technique and the homeostasis model assessment in hypertension. Am J Hypertens 2001; 14: 51-53.
36. Chen H, Sullivan G, Yue LQ, Katz A, Quon MJ. QUICKI is a useful index of insulin sensitivity in subjects with hypertension. Am J Physiol Endocrinol Metab 2003; 284: 804-812.
37. Oterdoom LH, de Vries AP, van Son WJ, van der Heide JJ, Ploeg RJ, Gansevoort RT et al. Validation of insulin resistance indexes in a stable renal transplant population. Diabetes Care 2005; 28: 2424-2429.
38. Jayagopal V, Kilpatrick ES, Jennings PE, Hepburd DA, Atkin SL. Biological variation of homeostasis model assessment-derived insulin resistance in type 2 diabetes. Diabetes Care 2002; 25: 2022-2025.
39. Mooy JM, Grootenhuis PA, de VH, Kostense PJ, Popp-Snijders C, Bouter LM et al. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: The Horn Study. Diabetologia 1996; 39: 298-305.
40. Soop M, Nygren J, Brisma K, Thorell A, Ljungqvist O. The hyperinsulinaemic-euglycaemic glucose clamp: Reproducibility and metabolic effects of prolonged insulin infusion in healthy subjects. Clin Sci (London) 2000; 98: 367-374.
41. Bokemark L, Froden A, Attvall S, Wikstand J, Fagerberg B. The euglycemic hyperinsulinemic clamp examination: Variability and reproducibility. Scand J Clin Lab Invest 2000; 60: 27-36.